Clinical Trial: A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598422) titled 'A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome' on May 14.

Brief Summary: The aim of this study is to assess the effectiveness and safety of Ilaris (canakinumab) in clinical use in patients with Schnitzler's syndrome.

Study Start Date: May 31

Study Type: OBSERVATIONAL

Condition: Schnitzler Syndrome

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Disclaimer: Curated by HT Syndication....